JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 2.55 HKD 3.66%
Updated: May 20, 2024

JW (Cayman) Therapeutics Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

JW (Cayman) Therapeutics Co Ltd
Additional Paid In Capital Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Additional Paid In Capital
¥6.1B
CAGR 3-Years
0%
CAGR 5-Years
172%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Additional Paid In Capital
¥81.4B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Additional Paid In Capital
¥27.3B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Additional Paid In Capital
¥3.3B
CAGR 3-Years
95%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Additional Paid In Capital
¥48m
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-29%
Imeik Technology Development Co Ltd
SZSE:300896
Additional Paid In Capital
¥3.4B
CAGR 3-Years
190%
CAGR 5-Years
89%
CAGR 10-Years
N/A

See Also

What is JW (Cayman) Therapeutics Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
6.1B CNY

Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Additional Paid In Capital amounts to 6.1B CNY.

What is JW (Cayman) Therapeutics Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
172%

Over the last year, the Additional Paid In Capital growth was 0%.